• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于对大鼠睡眠药物效应的判别分析进行精神药物类别计算机预测。

Computer-based prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep.

作者信息

Ruigt G S, Engelen S, Gerrits A, Verbon F

机构信息

Department of Neuropharmacology, Organon International, BH Oss, The Netherlands.

出版信息

Neuropsychobiology. 1993;28(3):138-53. doi: 10.1159/000119016.

DOI:10.1159/000119016
PMID:8278029
Abstract

The goal of the present study was to classify psychotropic drugs on the basis of EEG-defined rat sleep-waking behaviour. Using an automated sleep classification system it was found that some of the drug-induced changes in sleep-waking behaviour were specific for the pharmacotherapeutic treatment class to which the drug belonged. In several preliminary experiments we further found that drugs may have effects on rat EEG independent of their effects on rat sleep-waking behaviour and that these pharmaco-EEG effects may be different for the various sleep and waking stages. By analysing sleep class-independent EEG-spectral parameters a single drug effect score can, moreover, be obtained giving information on drug pharmacodynamics. The drug-induced changes in sleep-waking behaviour were used to classify a large number of drugs into several therapy classes by means of a discriminant analysis procedure. Antidepressants, antipsychotics and stimulants were discriminated successfully from each other and from placebo by this system, whereas nootropics classified as placebo. Anxiolytics, hypnotics and anticonvulsants classified poorly. Their classification is hampered by the lack of specific compounds. Assigned drug class and assignment probability were dose dependent. In the discussion of the present study it is suggested that animal pharmaco-sleep and pharmaco-EEG studies are not mutually exclusive approaches, but that they may complement each other.

摘要

本研究的目的是根据脑电图定义的大鼠睡眠-觉醒行为对精神药物进行分类。使用自动睡眠分类系统发现,一些药物引起的睡眠-觉醒行为变化对于药物所属的药物治疗类别具有特异性。在几个初步实验中,我们进一步发现药物可能对大鼠脑电图有影响,而与其对大鼠睡眠-觉醒行为的影响无关,并且这些药物脑电图效应在不同的睡眠和觉醒阶段可能有所不同。此外,通过分析与睡眠类别无关的脑电图频谱参数,可以获得一个单一的药物效应评分,提供有关药物药效学的信息。通过判别分析程序,利用药物引起的睡眠-觉醒行为变化将大量药物分为几个治疗类别。该系统成功地将抗抑郁药、抗精神病药和兴奋剂彼此区分开来,并与安慰剂区分开来,而益智药则被归类为安慰剂。抗焦虑药、催眠药和抗惊厥药的分类较差。它们的分类受到缺乏特异性化合物的阻碍。指定的药物类别和指定概率与剂量有关。在本研究的讨论中,有人提出动物药物睡眠和药物脑电图研究不是相互排斥的方法,而是可以相互补充。

相似文献

1
Computer-based prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep.基于对大鼠睡眠药物效应的判别分析进行精神药物类别计算机预测。
Neuropsychobiology. 1993;28(3):138-53. doi: 10.1159/000119016.
2
A comparison of doubly hierarchical discriminant analyses for multiple class longitudinal data from EEG experiments.来自脑电图实验的多类别纵向数据的双重分层判别分析比较。
J Biopharm Stat. 2008;18(6):1120-35. doi: 10.1080/10543400802369111.
3
Correction for model selection bias using a modified model averaging approach for supervised learning methods applied to EEG experiments.使用改进的模型平均方法对应用于脑电图实验的监督学习方法进行模型选择偏差校正。
J Biopharm Stat. 2010 Jul;20(4):768-86. doi: 10.1080/10543401003618744.
4
Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA).通过单导联药物脑电图、脑电图地形图和断层扫描(低分辨率电磁断层成像)对精神药物的药效学进行分类和评估。
Methods Find Exp Clin Pharmacol. 2002;24 Suppl C:97-120.
5
EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs.脑电图地形图和断层扫描(LORETA)在精神药物药效学分类与评估中的应用
Clin EEG Neurosci. 2006 Apr;37(2):66-80. doi: 10.1177/155005940603700205.
6
Pharmaco-EEG in psychiatry.精神病学中的药物脑电图
Clin EEG Neurosci. 2006 Apr;37(2):81-98. doi: 10.1177/155005940603700206.
7
The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.代谢型谷氨酸(mGLU)2/3受体拮抗剂LY341495 [2S - 2 - 氨基 - 2 -(1S,2S - 2 - 羧基环丙基 - 1 - 基)- 3 -(呫吨 - 9 - 基)丙酸]可刺激大鼠觉醒和快速脑电图功率,并阻断mGLU2/3受体激动剂ly379268 [( - )-2 - 氧杂 - 4 - 氨基双环[3.1.0]己烷 - 4,6 - 二羧酸]的作用。
J Pharmacol Exp Ther. 2005 Feb;312(2):826-33. doi: 10.1124/jpet.104.076547. Epub 2004 Sep 21.
8
Effects of the selective alpha 1-adrenoceptor blocker prazosin on EEG sleep and waking stages in the rat.选择性α1肾上腺素能受体阻滞剂哌唑嗪对大鼠脑电图睡眠和清醒阶段的影响。
Neuropsychobiology. 1989;21(2):100-3. doi: 10.1159/000118560.
9
Ritanserin-induced changes in sleep-waking phases in rats.
Acta Physiol Pharmacol Bulg. 1995;21(4):87-92.
10
HZI systems for EEG parametrization and classification of psychotropic drugs.
Pharmakopsychiatr Neuropsychopharmakol. 1979 Jan;12(1):4-19. doi: 10.1055/s-0028-1094590.

引用本文的文献

1
Prospects of Electrocorticography in Neuropharmacological Studies in Small Laboratory Animals.皮质脑电图在小型实验动物神经药理学研究中的应用前景
Brain Sci. 2024 Jul 31;14(8):772. doi: 10.3390/brainsci14080772.
2
Interacting Influences of Sleep, Pain, and Analgesic Medications on Sleep Studies in Rodents.睡眠、疼痛和镇痛药物对啮齿动物睡眠研究的相互影响
Comp Med. 2019 Dec 1;69(6):571-578. doi: 10.30802/AALAS-CM-19-000029. Epub 2019 Jun 18.
3
Differences between Physostigmine- and Yohimbine-induced States Are Visualized in Canonical Space Constructed from EEG during Natural Sleep-wake Cycle in Rats.
电针对电针预处理对慢性不可预见性温和应激模型大鼠抑郁样行为及海马组织中 mTOR 信号通路的影响。
Exp Neurobiol. 2011 Mar;20(1):54-65. doi: 10.5607/en.2011.20.1.54. Epub 2011 Mar 31.
4
Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.测试c-fos表达谱分析在辅助精神活性药物治疗分类方面的有效性。
Psychopharmacology (Berl). 2004 Jan;171(3):306-21. doi: 10.1007/s00213-003-1579-7. Epub 2003 Sep 10.
5
A risk-benefit assessment of mirtazapine in the treatment of depression.米氮平治疗抑郁症的风险效益评估。
Drug Saf. 1997 Oct;17(4):251-64. doi: 10.2165/00002018-199717040-00005.